Skip to main content

Table 1 Clinicopathological parameters of 64 ovarian cancer patients

From: HHLA2 predicts better survival and exhibits inhibited proliferation in epithelial ovarian cancer

Characteristics No
Age, years
 ≥ 50 42
 < 50 22
Histological type
 Serous Adenocarcinoma 50
 Mucinous Adenocarcinoma 2
 Endometrioid Adenocarcinoma 6
 Clear Cell Carcinoma 5
 Transitional Cell Carcinoma 1
FIGO stage
 I 9
 II 6
 III 36
 IV 13
Differentiation
 Poor 27
 Moderate 24
 Well 13
Ascites
 +  11
 − 53
Vessel Invasion
 +  3
 − 61
Lymph Node
 +  8
 − 56
Platinum Sensitivity
 Sensitive 50
 Resistance 14
Relapse
 +  27
 − 37